Emilia Giugliano

The efficacy of imatinib mesylate in patients with FIP1L1-PDGFR -positive hypereosinophilic syndrome. Results of a multicenter prospective study

Michele Baccarani, Daniela Cilloni, Michela Rondoni et al. · Haematologica · 2007 · 195 citations · Full text

Medicine, Hematology, Pharmacotherapy +13

The NF-κB pathway blockade by the IKK inhibitor PS1145 can overcome Imatinib resistance

Daniela Cilloni, F. Messa, Francesca Arruga et al. · Leukemia · 2005 · 122 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +9

Imatinib and pegylated human recombinant interferon-α2b in early chronic-phase chronic myeloid leukemia

Michele Baccarani, Giovanni Martinelli, Gianantonio Rosti et al. · Blood · 2004 · 106 citations · Full text

Pharmacy, Oncology, Pharmacotherapy +10

Increase in platelet count in older, poor‐risk patients with acute myeloid leukemia or myelodysplastic syndrome treated with valproic acid and all‐trans retinoic acid

Chiara Pilatrino, Daniela Cilloni, Emanuela Messa et al. · Cancer · 2005 · 100 citations · Full text

Medicine, Hematology, Pharmacology +16

Chronic myeloid leukemia: a prospective comparison of interphase fluorescence in situ hybridization and chromosome banding analysis for the definition of complete cytogenetic response: a study of the GIMEMA CML WP

Nicoletta Testoni, Giulia Marzocchi, Simona Luatti et al. · Blood · 2009 · 80 citations

Life Sciences, Hematology, Oncology +17